000 | 01348 a2200373 4500 | ||
---|---|---|---|
005 | 20250513125710.0 | ||
264 | 0 | _c19971215 | |
008 | 199712s 0 0 eng d | ||
022 | _a0022-2275 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMendez, A J | |
245 | 0 | 0 |
_aCholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. _h[electronic resource] |
260 |
_bJournal of lipid research _cSep 1997 |
||
300 |
_a1807-21 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aApolipoprotein A-I _xmetabolism |
650 | 0 | 4 |
_aApolipoproteins _xmetabolism |
650 | 0 | 4 |
_aBiological Transport _xdrug effects |
650 | 0 | 4 |
_aBiological Transport, Active _xdrug effects |
650 | 0 | 4 | _aCell Division |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCholesterol _xmetabolism |
650 | 0 | 4 |
_aCholesterol Esters _xmetabolism |
650 | 0 | 4 | _aDiffusion |
650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
650 | 0 | 4 | _aEsterification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLipoproteins, HDL _xmetabolism |
650 | 0 | 4 |
_aPotassium Cyanide _xtoxicity |
650 | 0 | 4 |
_aTangier Disease _xmetabolism |
650 | 0 | 4 | _aTemperature |
773 | 0 |
_tJournal of lipid research _gvol. 38 _gno. 9 _gp. 1807-21 |
|
999 |
_c9297177 _d9297177 |